Sequana Medical

Human heart
#Cancer research #Clinical trials #Heart failure #Liver disease #Sequana Medical

Sequana announces first patient enrolled in heart failure trial 

Sequana Medical, a company targeting fluid overload in liver disease, heart failure and cancer, has enrolled the first patient in its MOJAVE study.  MOJAVE, a randomised controlled Phase I/IIa study in the US, will evaluate the safety and efficacy of the company’s second-generation DSR product (DSR 2.0)… Read More

#News

Congestive heart failure
#Cardiovascular disease #FDA #Heart failure #Phase I trial #Sequana Medical #United States

FDA reviews IND for congestive heart failure treatment

Sequana Medical has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for its second-generation DSR product (DSR 2.0) for the treatment of congestive heart failure. Fluid accumulation in heart failure patients is caused by the retention of too much sodium. The DSR drug-based… Read More

#News #Regulatory